CERo Therapeutics Stock (NASDAQ:PBAX)


OwnershipFinancialsChart

Previous Close

$5.48

52W Range

$4.12 - $12.80

50D Avg

$10.39

200D Avg

$10.74

Market Cap

$36.47M

Avg Vol (3M)

$8.08K

Beta

0.04

Div Yield

-

PBAX Company Profile


Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Nov 30, 2021

Website

-

PBAX Performance


PBAX Financial Summary


Dec 22Dec 21
Revenue$254.83K-
Operating Income$-68.58K$-332.03K
Net Income$-667.74K$-315.55K
EBITDA$-5.74M$-332.03K
Basic EPS$-0.04$-0.01
Diluted EPS$-0.04$-0.01

Fiscal year ends in Dec 22 | Currency in USD

Peer Comparison


TickerCompany
TGAATarget Global Acquisition I Corp.